Cuur Diagnostics

Gastrointestinal Panel

GASTROINTESTINAL PANEL

CUUR Diagnostics is dedicated to maintaining the largest data set of infectious disease targets available in the world.

Gastrointestinal infections are among the most commonly encountered infections in primary care today. While they may not always be severe and may often resolve rapidly, they can be serious in specific healthcare settings or patient populations when caused by a variety of bacteria, viruses and parasites. Despite tremendous progress in both diagnosis and treatment of GI Tract Infections, pathogens may be underestimated as a cause of diarrhea as a result of current type of testing commonly used to accurately identify the right pathogen as the cause.

CUUR Diagnostics rapidly identifies a broad range of potential bacterial, viral or parasitic pathogens with extreme sensitivity and specificity. We use targeted assays for nosocomial diarrhea and syndromic panels for community acquired/traveler’s diarrhea that align with recommended guidelines. CUUR Diagnostics empowers providers to improve efficiency and effectiveness of clinical outcomes by reducing turnaround time, consolidating sample testing, and reducing opportunities for human error delivering optimal results for patient care, antimicrobial stewardship, and infection control.

Helix DNA
TARGETS
[table “” not found /]

Infectious Disease Care

D I A G N O S T I C S

STATISTICALLY SPEAKING
  • The CDC reports Infectious Diarrhea kills 2,195 children every day worldwide making this the leading cause of death among children under age 5
  • Over 200 million episodes per year of infectious gastroenteritis reported in the US